CONTROL OF SCHWANN CELL DIFFERENTIATION

施万细胞分化的控制

基本信息

项目摘要

The mechanisms by which the extracellular matrix influences a cell's decision to proliferate or differentiate are poorly understood. During the last decade, many extracellular matrix-binding proteins were described and they are now known to be members of a large family of integrin receptor II IL it is becoming appreciated that integrins not only bind to matrix components but also interact with.the cytoskeleton and initiate signal transduction pathways that may be critical for cellular proliferation and differentiation. The Schwann cell (SC), the myelin forming cell of the peripheral nervous system, is an example of a cell that is absolutely dependent on the deposition of extracellular matrix in order to differentiate in response to axonal signals expressed by neurons. Although this observation was made nearly 15 years ago, we are only now ready to delineate the molecular mechanisms underlying this interdependence of extracellular matrix deposition and SC differentiation. This proposal provides experimental strategies that will allow ascertainment of the following: 1) whether the alpha6beta1 and alpha 6 Beta4 integrins, known to be expressed by SCs, play a role in SC differentiation into myelin-forming cells, 2) whether Beta1 or Beta4 integrin activation, or the actin-based cytoskeleton, are associated with expression of myelin-specific proteins or their mRNAs, 3) whether Beta1 or Beta4 integrins interact with actin, actin binding proteins, and signaling molecules such as the newly-described focal adhesion kinase, to form a stable transmembrane complex that forms upon SC binding to the extracellular matrix, and 4) whether tyrosine phosphorylation events are associated with and necessary for integrin-mediated signal transduction. These studies will be conducted in co-cultures of SCs with sensory neurons that allow 1) precise control of SC proliferation and differentiation, 2) perturbation of the expression of single molecules hypothesized to play critical roles in SC differentiation, and 3) that are amenable to analysis using cellular, molecular, biochemical, and morphological techniques. The information provided by these studies is crucial to our understanding of the mechanisms controlling normal cell development and will be directly applicable to efforts to control tumorigenesis in diseases such as neurofibromatosis, as well as to develop therapeutic strategies to alleviate demyelination caused by injury to the nervous system or by attack on the nervous system by immune mechanisms.
细胞外基质影响细胞的机制 人们对增殖或分化的决定知之甚少。期间 在过去的十年中,许多细胞外基质结合蛋白被 描述,现在已知他们是一个大家庭的成员 整合素受体 II IL 人们逐渐认识到整合素不 不仅与基质成分结合,还与细胞骨架相互作用 并启动可能至关重要的信号转导途径 细胞增殖和分化。施万细胞 (SC) 周围神经系统的髓磷脂形成细胞是一个例子 绝对依赖于细胞外沉积的细胞 矩阵以便区分所表达的轴突信号 由神经元。尽管这一观察是近 15 年前做出的,但我们 现在才准备好描述其背后的分子机制 细胞外基质沉积和 SC 的相互依赖性 差异化。该提案提供了实验策略,将 允许确定以下内容: 1) 是否 alpha6beta1 和 已知由 SC 表达的 α 6 Beta4 整合素在 SC 中发挥作用 分化为髓磷脂形成细胞,2) 无论是 Beta1 还是 Beta4 整合素激活或基于肌动蛋白的细胞骨架与 髓磷脂特异性蛋白或其 mRNA 的表达,3) 是否 Beta1 或 Beta4 整合素与肌动蛋白、肌动蛋白结合蛋白相互作用,以及 信号分子,例如新描述的粘着斑激酶, 形成稳定的跨膜复合物,该复合物在 SC 与 细胞外基质,4) 酪氨酸磷酸化事件是否 与整合素介导的信号转导相关且是必需的。 这些研究将在 SC 与感官的共培养中进行 神经元可以 1)精确控制 SC 增殖和 分化,2)单分子表达的扰动 假设在 SC 分化中发挥关键作用,并且 3) 适合使用细胞、分子、生物化学和 形态学技术。这些研究提供的信息是 对于我们理解控制正常细胞的机制至关重要 的发展并将直接应用于控制工作 神经纤维瘤病等疾病的肿瘤发生,以及 制定治疗策略以减轻由脱髓鞘引起的脱髓鞘 神经系统损伤或免疫系统攻击神经系统 机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CRISTINA Maria FERNANDEZ-VALLE其他文献

CRISTINA Maria FERNANDEZ-VALLE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CRISTINA Maria FERNANDEZ-VALLE', 18)}}的其他基金

Preclinical Testing of PI3K Inhibitors for Vestibular Schwannomas
PI3K 抑制剂治疗前庭神经鞘瘤的临床前测试
  • 批准号:
    10447797
  • 财政年份:
    2018
  • 资助金额:
    $ 11.96万
  • 项目类别:
Preclinical Testing of PI3K Inhibitors for Vestibular Schwannomas
PI3K 抑制剂治疗前庭神经鞘瘤的临床前测试
  • 批准号:
    10238743
  • 财政年份:
    2018
  • 资助金额:
    $ 11.96万
  • 项目类别:
ZEISS Spinning Disc/LSM700 Point Scanning Confocal Microscope with Incubation Sys
蔡司转盘/LSM700 点扫描共焦显微镜,带孵化系统
  • 批准号:
    7794517
  • 财政年份:
    2010
  • 资助金额:
    $ 11.96万
  • 项目类别:
Identification of Novel Drug Targets For Use in Preventing Deafness Caused by NF2
鉴定用于预防 NF2 引起的耳聋的新药物靶点
  • 批准号:
    8278031
  • 财政年份:
    2009
  • 资助金额:
    $ 11.96万
  • 项目类别:
Identification of Novel Drug Targets For Use in Preventing Deafness Caused by NF2
鉴定用于预防 NF2 引起的耳聋的新药物靶点
  • 批准号:
    8495967
  • 财政年份:
    2009
  • 资助金额:
    $ 11.96万
  • 项目类别:
Identification of Novel Drug Targets For Use in Preventing Deafness Caused by NF2
鉴定用于预防 NF2 引起的耳聋的新药物靶点
  • 批准号:
    7699548
  • 财政年份:
    2009
  • 资助金额:
    $ 11.96万
  • 项目类别:
Identification of Novel Drug Targets For Use in Preventing Deafness Caused by NF2
鉴定用于预防 NF2 引起的耳聋的新药物靶点
  • 批准号:
    8082728
  • 财政年份:
    2009
  • 资助金额:
    $ 11.96万
  • 项目类别:
Identification of Novel Drug Targets For Use in Preventing Deafness Caused by NF2
鉴定用于预防 NF2 引起的耳聋的新药物靶点
  • 批准号:
    7878605
  • 财政年份:
    2009
  • 资助金额:
    $ 11.96万
  • 项目类别:
Mechanisms Modulating Cytoskeletal Dynamics During Schwann Cell Myelination
雪旺细胞髓鞘形成过程中细胞骨架动力学的调节机制
  • 批准号:
    7737261
  • 财政年份:
    2009
  • 资助金额:
    $ 11.96万
  • 项目类别:
CONTROL OF SCHWANN CELL DIFFERENTIATION
施万细胞分化的控制
  • 批准号:
    2329944
  • 财政年份:
    1995
  • 资助金额:
    $ 11.96万
  • 项目类别:

相似海外基金

A novel motility system driven by two classes of bacterial actins MreB
由两类细菌肌动蛋白 MreB 驱动的新型运动系统
  • 批准号:
    22KJ2613
  • 财政年份:
    2023
  • 资助金额:
    $ 11.96万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
The structural basis of plasmid segregation by bacterial actins
细菌肌动蛋白分离质粒的结构基础
  • 批准号:
    342887
  • 财政年份:
    2016
  • 资助金额:
    $ 11.96万
  • 项目类别:
    Operating Grants
The structural basis for plasmid segregation by bacterial actins
细菌肌动蛋白分离质粒的结构基础
  • 批准号:
    278338
  • 财政年份:
    2013
  • 资助金额:
    $ 11.96万
  • 项目类别:
    Operating Grants
Cytoplasmic Actins in Maintenance of Muscle Mitochondria
细胞质肌动蛋白在维持肌肉线粒体中的作用
  • 批准号:
    8505938
  • 财政年份:
    2012
  • 资助金额:
    $ 11.96万
  • 项目类别:
Differential Expression of the Diverse Plant Actins
多种植物肌动蛋白的差异表达
  • 批准号:
    7931495
  • 财政年份:
    2009
  • 资助金额:
    $ 11.96万
  • 项目类别:
Studies on how actins and microtubules are coordinated and its relevancy.
研究肌动蛋白和微管如何协调及其相关性。
  • 批准号:
    19390048
  • 财政年份:
    2007
  • 资助金额:
    $ 11.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Suppression of Arabidopsis Reproductive Actins
拟南芥生殖肌动蛋白的抑制
  • 批准号:
    6546977
  • 财政年份:
    2003
  • 资助金额:
    $ 11.96万
  • 项目类别:
Suppression of Arabidopsis Reproductive Actins
拟南芥生殖肌动蛋白的抑制
  • 批准号:
    6655612
  • 财政年份:
    2003
  • 资助金额:
    $ 11.96万
  • 项目类别:
Interaction of myosin with monomeric actins
肌球蛋白与单体肌动蛋白的相互作用
  • 批准号:
    5311554
  • 财政年份:
    2001
  • 资助金额:
    $ 11.96万
  • 项目类别:
    Priority Programmes
STRUCTURE/INTERACTIONS OF ACTINS AND ACTIN-BINDING PROTEIN
肌动蛋白和肌动蛋白结合蛋白的结构/相互作用
  • 批准号:
    6316669
  • 财政年份:
    2000
  • 资助金额:
    $ 11.96万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了